Cargando…

Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy

BACKGROUND: Ambigous results exist on fetuin-A as marker for vascular disease in type 2 diabetes. This study aims to define the role of fetuin-A as marker for micro- and macrovascular disease in a high risk population of patients with type 2 diabetes mellitus and early diabetic nephropathy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roos, Marcel, Oikonomou, Dimitrios, von Eynatten, Maximilian, Luppa, Peter B, Heemann, Uwe, Lutz, Jens, Baumann, Marcus, Nawroth, Peter P, Bierhaus, Angelika, Humpert, Per M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949712/ https://www.ncbi.nlm.nih.gov/pubmed/20822519 http://dx.doi.org/10.1186/1475-2840-9-48

Ejemplares similares

Urinary Adiponectin Excretion: A Novel Marker for Vascular Damage in Type 2 Diabetes
por: von Eynatten, Maximilian, et al.
Publicado: (2009)

Proximal Neuropathic Lesions in Distal Symmetric Diabetic Polyneuropathy: Findings of high-resolution magnetic resonance neurography
por: Pham, Mirko, et al.
Publicado: (2011)

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
por: Panduru, Nicolae M., et al.
Publicado: (2013)

Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
por: Humpert, Per M, et al.
Publicado: (2007)

Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy
por: Burkhardt, Klaus, et al.
Publicado: (2009)

Sustained Effects of a Mindfulness-Based Stress-Reduction Intervention in Type 2 Diabetic Patients: Design and first results of a randomized controlled trial (the Heidelberger Diabetes and Stress-Study)
por: Hartmann, Mechthild, et al.
Publicado: (2012)

Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray
por: Inoue, Kentaro, et al.
Publicado: (2013)

The Complexity of Sporadic Alzheimer's Disease Pathogenesis: The Role of RAGE as Therapeutic Target to Promote Neuroprotection by Inhibiting Neurovascular Dysfunction
por: Perrone, Lorena, et al.
Publicado: (2012)

Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study
por: Oikonomou, Dimitrios, et al.
Publicado: (2014)

C. elegans as Model for the Study of High Glucose– Mediated Life Span Reduction
por: Schlotterer, Andreas, et al.
Publicado: (2009)

Fetuin-A and fetal growth in gestational diabetes mellitus
por: Wang, Wen-Juan, et al.
Publicado: (2020)

Clinical Trials on Diabetic Nephropathy: A Cross-Sectional Analysis
por: Modafferi, Sergio, et al.
Publicado: (2019)

Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes
por: Stefan, Norbert, et al.
Publicado: (2008)

Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy
por: Zhao, Chunming, et al.
Publicado: (2015)

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease
por: Lorant, David Peter, et al.
Publicado: (2011)

Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development
Publicado: (1975)

Blood glucose, diabetes and metabolic control in patients with community-acquired pneumonia
por: Lepper, Philipp M., et al.
Publicado: (2020)

Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes
por: Ochieng, Josiah, et al.
Publicado: (2018)

Magnetic resonance neurography detects diabetic neuropathy early and with Proximal Predominance
por: Pham, Mirko, et al.
Publicado: (2015)

Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation
por: Khadir, Abdelkrim, et al.
Publicado: (2018)

Fetuin-A Inhibits Placental Cell Growth and Ciliogenesis in Gestational Diabetes Mellitus
por: Wang, Chia-Yih, et al.
Publicado: (2019)

Fetuin-A and risk of diabetes-related vascular complications: a prospective study
por: Birukov, Anna, et al.
Publicado: (2022)

The impact of Ramadan fasting on Fetuin-A level in type 2 diabetes mellitus
por: Harbuwono, Dante S., et al.
Publicado: (2021)

Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis
por: Bopp, Christian, et al.
Publicado: (2008)

Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation
por: Lutz, Jens, et al.
Publicado: (2010)

Serum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults
por: Song, Aiyun, et al.
Publicado: (2011)

Association of fetuin-A with dyslipidemia and insulin resistance in type-II Diabetics of Pakistani population
por: Fatima, Fasiha, et al.
Publicado: (2020)

Clinical Significance of the Fetuin-A-to-Adiponectin Ratio in Obese Children and Adolescents with Diabetes Mellitus
por: Ahn, Moon-Bae, et al.
Publicado: (2021)

Association between carotid diameter and the advanced glycation endproduct N(ε)-Carboxymethyllysine (CML)
por: Baumann, Marcus, et al.
Publicado: (2009)

Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy
por: Winther, Signe Abitz, et al.
Publicado: (2021)

Nanobacteria Are Mineralo Fetuin Complexes
por: Raoult, Didier, et al.
Publicado: (2008)

Fetuin-A levels in hyperthyroidism
por: Pamuk, Barış Onder, et al.
Publicado: (2013)

Fetuin-A is also an adipokine
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes
por: Eraso, Luis H., et al.
Publicado: (2010)

Plasma Levels of Fetuin-A and Hepatic Enzymes and Risk of Type 2 Diabetes in Women in the U.S.
por: Sun, Qi, et al.
Publicado: (2013)

Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
por: Teismann, Peter, et al.
Publicado: (2012)

Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy
por: Shahzad, Khurrum, et al.
Publicado: (2016)

Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
por: Groop, Per-Henrik, et al.
Publicado: (2013)

Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products
por: Ehlermann, Philipp, et al.
Publicado: (2006)

Diabetic nephropathy
por: Zelmanovitz, Themis, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3h6b4gqk4gmpdntkp44sa7oo0j